As computers get smaller and smaller, contamination becomes a bigger issue in manufacturing them. Even the vacuum chambers used in “clean rooms” aren’t completely free of wayward particles-and even tiny particles can ruin an expensive set of silicon wafers.
Existing defenses against these trespassers aren’t particularly sharp. They work by periodically checking the surfaces of silicon wafers for impurities. These methods are hit-and-miss, and they’re helpless against particles smaller than two-tenths of a micrometer.
Now William Reents, a chemist at Lucent Technologies’ Bell Labs, has put together a laser-based instrument to zero in on particles as small as one-thousandth of a micrometer, a twohundredfold improvement. What’s more, the device can determine in real time the chemical composition of the contamination, helping pinpoint its source.
Reents’ invention pulls particles through a thin capillary tube. A laser zaps the particles, ionizing the atoms; the ions are then accelerated toward a detector. The time it takes for each ion to reach the detector depends on the ion’s mass, and that information can be used to determine the chemical makeup of the particle.
Tests are under way to see how the detector performs attached to actual clean-room equipment. If all goes well, Bell Labs hopes to entice an equipment maker to produce an instrument rugged enough to stand up to manufacturing conditions.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.